Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS3233 and Metformin in PCOS
NCT01999686Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Oct 2014
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS3233 in polycystic ovary syndrome (PCOS), insulin resistance (IR), sponsored by Dexa Medica. Started Oct 2014; status: completed.
02
Drugs
DLBS3233
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)
Beyond the preview
Go deeper on NCT01999686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01999686.